Clinical Trial: Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: The Effect of Lanreotide on Volume of Polycystic Liver and Kidney in Autosomal Dominant Polycystic Kidney Disease

Brief Summary: The aim of this study is to determine the effect of Lanreotide on polycystic liver and kidneys in patients with autosomal dominant polycystic kidney disease.